Annual Drug Patent Expirations for TARGINIQ
Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug.
Drug patent litigation for TARGINIQ.
This drug has two hundred and sixty-six patent family members in forty-four countries.
The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. Additional details are available on the naloxone hydrochloride; oxycodone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
